Gothenburg, Sweden — Denator AB announced today that the Proteomics group at Australia’s CSIRO Livestock Industries has integrated the Stabilizor® T1 system into its proteomic workflow and will act as a reference site for the company’s technology.

Based on the company’s proprietary heat inactivation technology, Stabilizor T1 stabilizes tissue samples from the crucial moment of sampling, permanently eliminating the activity of degradative enzymes, without the use of additives.

As a reference site, the Proteomics group at CSIRO Livestock Industries will gain early access to new products for stabilization of biological samples.

CSIRO Senior Research Scientist Dr Michelle Colgrave explained: “CSIRO conducts a number of proteomics research projects, complementing our genomic efforts to benefit Australia’s livestock industry and improve human health. We focus on identifying novel proteins, their functions and post-translational modifications that are associated with commercially important livestock traits and diseases. Our evaluation of this novel stabilization device, Stabilizor T1, has demonstrated its utility in maintaining sample integrity in frozen hypothalamic tissue.”

Olof Sköld, CEO at Denator, stated: “CSIRO is a well-respected organization and we are delighted that it has demonstrated such confidence in our system. We look forward to continuing working closely with Dr Colgrave and her team in the future.”

About CSIRO

CSIRO, the Commonwealth Scientific and Industrial Research Organisation, is Australia’s national science agency, and one of the largest and most diverse research organisations in the world. It provides scientific solutions for industry, society and the environment. Established in 1926, CSIRO is the single largest employer of scientists in Australia, with more than 6 500 people conducting and assisting with scientific research at 55 sites in Australia and globally.

About Denator

Denator develops and sells products that stabilize biological tissues and fluids from the moment of sampling. Stabilization and standardization of sampling processes upstream significantly enhances the quality of data obtained from analytical techniques used downstream. In proteomic and peptidomic investigations, enhanced data quality increases the reliability of data interpretation and can reveal novel proteins and peptides that would be lost or undetectable when using conventional preparation techniques. Based upon the company’s proprietary heat-inactivation technology platform, Denator is developing solutions that enable scientists to stop sample degradation instantly and maintain the stability of sample components throughout the analytical workflow. Established in 2004, Denator is headquartered at the Biotech Center in Gothenburg, Sweden. For more information visit: www.denator.com